Unipath attempts to disguise redundancies in UK
This article was originally published in Clinica
Executive Summary
Unipath, a subsidiary of the Anglo-Dutch Unilever, a publicly-owned company, is in the process of reducing its workforce by a quarter. The company made the decision in June of this year to make redundant some 150 of its 550-strong UK staff, with cuts across the board in management and non-management positions. Unipath said the cuts were necessary because sales of its contraceptive device, Persona, had not taken off as the company expected.